There are also evidence showing that in human breast tumor cells and cancer cell lines there is no good correlation between the presence of PIK3CA gain-of-function mutations and the basal or growth factor stimulated PI3K and Akt activity (Stemke-Hale et al., 2008) suggesting that other regulatory mechanism may affect the status of PI3K activity. The gene discussed is AKT1; the disease is cancer.